相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coumarins as novel 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer
Koichiro Harada et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Perspectives in Understanding the Role of Human 17 beta-Hydroxysteroid Dehydrogenases in Health and Disease
Marc Meier et al.
STEROID ENZYMES AND CANCER (2009)
17 beta-Hydroxysteroid Dehydrogenases in Human Breast Cancer
Shuji Nagasaki et al.
STEROID ENZYMES AND CANCER (2009)
Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases
Donald Poirier
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Selective androgen receptor modulators as function promoting therapies
Shalender Bhasin et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities
Patrick Bydal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity
Emmanuel Bey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Selective inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17βHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells
Patricia Kruchten et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
The role of the heterocycle in bis(hydroxyphenyl)triazoles for inhibition of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) type 1 and type 2
Yaseen A. Al-Soud et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Pre-receptor steroid metabolism as target for pharmacological treatment
Jerzy Adamski
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors
Nigel Vicker et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Structure-activity study in the class of 6-(3′-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitors
Sandrine Marchais-Oberwinkler et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17β-hydroxysteroid dehydrogenase Type 3
Joanna M. Day et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors
Yannick Laplante et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Integrated view on 17beta-hydroxysteroid dehydrogenases
Gabriele Moeller et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Sex, Sex Steroids, and Brain Injury
Paco S. Herson et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2009)
Androgen biosynthetic pathways in the human prostate
Van Luu-The et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases
Emmanuel Bey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1:: Templates for design
Gillian M. Allan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
S. Gobec et al.
CURRENT MEDICINAL CHEMISTRY (2008)
New Cancer Drugs Targeting the Biosynthesis of Estrogens and Androgens
Donald Poirier
DRUG DEVELOPMENT RESEARCH (2008)
Design and validation of specific inhibitors of 17β-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
Joanna M. Day et al.
ENDOCRINE-RELATED CANCER (2008)
Design and synthesis of bisubstrate inhibitors of type 1 17β-hydroxysteroid dehydrogenase: Overview and perspectives
D. Fournier et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer
Joanna M. Day et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Substituted 6-phenyl-2-naphthols.: Potent and selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1):: Design, synthesis, biological evaluation, and pharmacokinetics
Sandrine Marchais-Oberwinkler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
Emmanuel Bey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives:: Potent and selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases
Mar-Tin Frotscher et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structure-function relationships in the mineralocorticoid receptor
Jyotsna B. Pippal et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
Crystallogenesis of steroid-converting enzymes and their complexes: Enzyme-ligand interaction studies and inhibitor design facilitated by complex structures
Mausumi Mazumdar et al.
CRYSTAL GROWTH & DESIGN (2007)
Steroids: partial synthesis in medicinal chemistry
James R. Hanson
NATURAL PRODUCT REPORTS (2007)
Human hydroxysteroid (17-β) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts
Bettina Husen et al.
ENDOCRINOLOGY (2006)
Expression of aromatase and 17β-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer -: An immunocytochemical study
D. Song et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase.: Part 3.: Identification of lead candidate
Jill Wood et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12
Nobuyuki Sakurai et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Focused libraries of 16-substituted estrone derivatives and modified E-ring steroids:: Inhibitors of 17β-hydroxysteroid dehydrogenase type 1
Nigel Vicker et al.
CHEMMEDCHEM (2006)
Novel, potent inhibitors of 17β-hydroxy steroid dehydrogenase type 1
GM Allan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Inhibitory effects of fluorine-substituted estrogens on the activity of 17beta-hydroxy steroid dehydrogenases
D Deluca et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme
B Husen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Structure and function of human 17β-hydroxysteroid dehydrogenases
P Lukacik et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
New inhibitors of 17β-hydroxysteroid dehydrogenase type 1
J Messinger et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
The regulation and inhibition of 17β-hydroxysteroid dehydrogenase in breast cancer
A Purohit et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Control of cell proliferation by steroids:: The role of 17HSDs
P Vihko et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Modification of estrone at the 6, 16, and 17 positions:: Novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1
GM Allan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Identification of novel functional inhibitors of 17β-hydroxysteroid dehydrogenase type III (17β-HSD3)
TE Spires et al.
PROSTATE (2005)
Localization of type 8 17β-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization
G Pelletier et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
E-ring modified steroids as novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1
DS Fischer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase.: Part 2.: SAR
D Gunn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Localization of type 5 17β-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization
G Pelletier et al.
CELL AND TISSUE RESEARCH (2005)
Novel and potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors
HR Lawrence et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
4,5-Disubstituted cis-pyrrolidinones as inhibitors of 17β-hydroxysteroid dehydrogenase II.: Part 1:: Synthetic approach
JH Cook et al.
TETRAHEDRON LETTERS (2005)
Localization of type 7 17 beta-hydroxysteroid dehydrogenase in mouse tissues In situ hybridization studies
G Pelletier et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
AH Payne et al.
ENDOCRINE REVIEWS (2004)
Glucocorticoid receptor antagonists: New tools to investigate disorders characterized by cortisol hypersecretion
BWMM Peeters et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2004)
Steroids and combinatorial chemistry
R Maltais et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2004)
Inhibition of type 2 17β-hydroxy steroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring:: structure-activity relationships
P Bydal et al.
STEROIDS (2004)
Endocrine and intracrine sources of androgens in women:: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone
F Labrie et al.
ENDOCRINE REVIEWS (2003)
Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents
VC Jordan
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Inhibitors of 17β-hydroxysteroid dehydrogenases
D Poirier
CURRENT MEDICINAL CHEMISTRY (2003)
17-β-hydroxysteroid dehydrogenase type 1:: computational design of active site inhibitors targeted to the Rossmann fold
WM Brown et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2003)
Cutaneous androgen metabolism: Basic research and clinical perspectives
WC Chen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Therapeutic potential of steroids for CNS disorders
NM Hamilton
EXPERT OPINION ON THERAPEUTIC PATENTS (2001)
Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers
HJ Smith et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2001)
A guide to 17β-hydroxysteroid dehydrogenases
J Adamski et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Inhibitors of type II 17β-hydroxysteroid dehydrogenase
D Poirier et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Analysis and characteristics of multiple types of human 17 beta-hydroxysteroid dehydrogenase
V Luu-The
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
Intracrinology:: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease
F Labrie et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Androgen receptor antagonists (antiandrogens): Structure-activity relationships
SM Singh et al.
CURRENT MEDICINAL CHEMISTRY (2000)
The influence of natural products upon drug discovery
DJ Newman et al.
NATURAL PRODUCT REPORTS (2000)
分享论文
